Bimekizumab Efficacy in Patients with Moderate to Severe Plaque Psoriasis and Hypertension, Elevated Body Mass Index, or Hyperglycemia: Results Through 3 years of Treatment in 5 Phase 3/3b Trials. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 8, n. 1, p. s308, 2024. DOI: 10.25251/skin.8.supp.308. Disponível em: https://skin.dermsquared.com/skin/article/view/2475. Acesso em: 18 apr. 2025.